ONKOCET Ltd. has exhibited the devices from its portfolio on the MEDTEC UK exhibition in Birmingham, April 2011 through our partner Medical & Partners.
The system's portability and speed of analysis add greatly to cutting the costs associated with the detection of ischemic heart disease.
Enables earlier detection of heart abnormalities.
Uses new information from ECG fluctuations that are usually ignored as "noise" by regular ECG devices.
The device allows a unique three dimensional color portrait of the heart's electrical field dynamics, allowing for rapid recognition and estimation of the heart's condition.
The HeartVue™ 6S System will depict a disease or stress level as an image instead of a line drawing electrocardiogram.
The Company's non-invasive screening system will provide more efficient clinical trials of new medications and treatment procedure results.
The system evaluates the stability of current heart conditions.
It improves disease-trend monitoring during medical treatment.
The system detects more cases of diseases and provides a better level of diagnosis with its improved sensitivity levels that can detect early warning signs that would normally be invisible with standard ECG devices. The device can detect small metabolic deviations preceding the dangerous ischemic damages of myocardium.
It differentiates arrhythmias and stresses.